DalsnaFinance

Savara Inc $SVRA

Health Care

Russell 2000 Texas
Create a scorecard
$4.49
-0.18 (-3.85%)
As of Oct 22, 2026, 3:57 PM EDT · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 7, 2026, the first target we tracked for SVRA.

Savara Inc (SVRA) is trading down at $4.49 (-3.85%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Analyst price targets on SVRA

One firm's current price target on Savara Inc: $10 — 123% above the current $4.49. Each is tracked to its date and scored the same way a member's call is.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Savara Inc revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$400.0K−$59.2M−$118.8MFY2016 revenue: $400.0KFY2016 net income: −$10.9M · Net margin −2730.8%'16FY2017 revenue: $0FY2017 net income: −$29.8M'17FY2018 net income: −$61.5M'18FY2019 revenue: $0FY2019 net income: −$78.2M'19FY2020 revenue: $257.0KFY2020 net income: −$49.6M · Net margin −19305.4%'20FY2021 net income: −$43.0M'21FY2022 net income: −$38.1M'22FY2023 net income: −$54.7M'23FY2024 net income: −$95.9M'24FY2025 net income: −$118.8M'25−100%−80%−60%−40%−20%0%FY2016 net margin: −2730.8% (off the scale, which stops at −100.0%)FY2020 net margin: −19305.4% (off the scale, which stops at −100.0%)
Savara Inc annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$400.0K$0—$0$257.0K—————
Growth (year over year)+640.7%−100.0%————————
Operating income−$10.9M−$30.0M−$70.0M−$79.0M−$49.3M−$41.5M−$38.8M−$60.0M−$103.2M−$123.5M
Operating margin−2737.0%———−19182.9%—————
Net income−$10.9M−$29.8M−$61.5M−$78.2M−$49.6M−$43.0M−$38.1M−$54.7M−$95.9M−$118.8M
Net margin−2730.8%———−19305.4%—————
EPS (diluted)−$5.62−$1.76−$1.85−$1.95−$0.84−$0.32−$0.25−$0.33−$0.48−$0.53
Balance sheet
Cash and equivalents$13.4M$22.1M$24.3M$49.8M$22.9M$34.0M$52.1M$26.6M$15.1M$33.2M
Total assets$28.9M$159.6M$152.3M$136.2M$97.7M$176.6M$139.8M$177.6M$212.9M$253.4M
Total liabilities$20.9M$40.3M$44.1M$34.5M$33.4M$32.1M$32.0M$37.2M$41.4M$50.3M
Long-term debt————$25.1M$17.3M$26.1M$26.3M$26.6M$29.9M
Shareholders' equity−$35.9M$119.3M$108.2M$101.7M$64.4M$144.5M$107.8M$140.4M$171.4M$203.1M
Cash flow
Operating cash flow−$8.37M−$28.2M−$39.3M−$45.1M−$39.8M−$40.1M−$34.6M−$51.1M−$89.1M−$101.0M
Capital expenditure$8.00K$495.0K$141.0K$148.0K$47.0K$57.0K$9.00K$296.0K$25.0K$22.0K
Free cash flow−$8.38M−$28.7M−$39.4M−$45.3M−$39.9M−$40.1M−$34.6M−$51.4M−$89.1M−$101.1M

From Savara Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Savara Inc

Headquarters
Austin, Texas From SEC filings, Oct 2026

Recent News (1)

More Health Care stocks

Browse all companies →